During tumor progression, many angiogenic activators support the process of angiogenesis, such as vascular endothelial growth factors (VEGFs), interleukin 8 (IL-8), tumor necrosis factor α (TNF-α) and hypoxia-inducible factors (HIFs) [147]. This evidence concerns the gene TNF and neoplasm.